UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000039435
Receipt number R000044933
Scientific Title Improvement in Cognitive and Motor Functions of Healthy Older Adults Following a VR Program Intervention: A Randomized Controlled Trial
Date of disclosure of the study information 2020/02/08
Last modified on 2020/09/15 22:35:59

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Improvement in Cognitive and Motor Functions of Older Adults Following a VR Program Intervention: A Randomized Controlled Trial

Acronym

Cognitive and Motor Functions Following a VR Program Intervention

Scientific Title

Improvement in Cognitive and Motor Functions of Healthy Older Adults Following a VR Program Intervention: A Randomized Controlled Trial

Scientific Title:Acronym

Cognitive and Motor Functions Following a VR Program Intervention

Region

Japan


Condition

Condition

Dementia, Mild Cognitive Impairment, Normal elderly, Lewy body dementia, Cerebrovascular disease, Cerebral infarction, Cerebral contusion, Cerebral hemorrhage, Aftereffect of cerebral hemorrhage, Basilar artery occlusion, Cerebral arteriosclerosis, Multiple cerebral infarction, Cerebral atrophy, Vascular dementia, Chronic subdural hematoma, Parkinson's disease, Parkinsonian syndrome, Bone and joint disease, Osteoporosls, Chronic articular rheumatism, Hemiparesis, Diabetes, Disuse syndrome, Locomotive Syndrome, Sarcopenia and frailty.

Classification by specialty

Psychiatry Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to examine the beneficial effect on cognitive and physical function by the VR program.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The 3D visuospatial test is compared before and after intervention for four weeks.

Key secondary outcomes

The neuropsychological testing and assessment for dementia (Mini-Mental State Examination, Instruction manual of the Japanese version of Montreal Cognitive Assessment, A Frontal Assessment Battery at bedside), Geriatric Depression Scale, WHO Quality of Life-BREF, the range of motion of the cervical spine range of motion


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -investigator(s) and assessor(s) are blinded

Control

No treatment

Stratification

YES

Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Device,equipment Behavior,custom

Interventions/Control_1

The VR intervention group attends 30 minutes of the VR program with HMD thrice a week for 4 weeks.

Interventions/Control_2

The waitlisted group does not participate in the intervention. After 4 weeks, there is the program as a service session.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

60 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Continue to participate in experiments thrice a week.
2)Continue to participate in the experiment for 4 weeks.

Key exclusion criteria

1) Dementia.
2) Blind, full deafness.

Target sample size

32


Research contact person

Name of lead principal investigator

1st name Atsushi
Middle name
Last name Hiyama

Organization

RIKEN

Division name

Physical Intelligence Transfer Technology Team

Zip code

103-0027

Address

5th floor, 1-4-1 Nihonbashi,Chuo-ku, Tokyo

TEL

+81(0)03-6225-2373

Email

atsushi.hiyama@riken.jp


Public contact

Name of contact person

1st name Atsuko
Middle name
Last name Miyazaki

Organization

RIKEN

Division name

Computational Engineering Applications Unit

Zip code

351-0198

Address

2-1 Hirosawa, Wako, Saitama 351-0198 Japan

TEL

+81(0)48-467-4952

Homepage URL


Email

atsuko.miyazaki.vj@riken.jp


Sponsor or person

Institute

RIKEN

Institute

Department

Personal name



Funding Source

Organization

RIKEN

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

RIKEN, Bio Safety and Ethics Section

Address

2-1 Hirosawa, Wako, Saitama 351-0198 Japan

Tel

+81(0)48-467-9293

Email

human@riken.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 02 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 01 Month 09 Day

Date of IRB

2020 Year 02 Month 06 Day

Anticipated trial start date

2020 Year 02 Month 15 Day

Last follow-up date

2020 Year 04 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 02 Month 08 Day

Last modified on

2020 Year 09 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044933


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name